Ceftibuten dihydrate

CAS No. 118081-34-8

Ceftibuten dihydrate ( Sch-39720 dihydrate )

Catalog No. M22032 CAS No. 118081-34-8

Ceftibuten dihydrate is the dihydrate form of ceftibuten, and is a third-generation cephalosporin with antibacterial activity.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
10MG 41 In Stock
25MG 74 In Stock
50MG 113 In Stock
100MG 168 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Ceftibuten dihydrate
  • Note
    Research use only, not for human use.
  • Brief Description
    Ceftibuten dihydrate is the dihydrate form of ceftibuten, and is a third-generation cephalosporin with antibacterial activity.
  • Description
    Ceftibuten dihydrate is the dihydrate form of ceftibuten, and is a third-generation cephalosporin with antibacterial activity.
  • Synonyms
    Sch-39720 dihydrate
  • Pathway
    GPCR/G Protein
  • Target
    Antibacterial
  • Recptor
    Bacterial;Antibiotic
  • Research Area
    Urinary system
  • Indication
    Pyelonephritis

Chemical Information

  • CAS Number
    118081-34-8
  • Formula Weight
    446.46
  • Molecular Formula
    C15H18N4O8S2
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:95 mg/mL (212.78 mM; Need ultrasonic)
  • SMILES
    C1C=C(N2C(S1)C(C2=O)NC(=O)C(=CCC(=O)O)C3=CSC(=N3)N)C(=O)O.O.O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. JONES, RONALD N. Ceftibuten: a review of antimicrobial activity, spectrum and other microbiologic features.[J]. Pediatric Infectious Disease Journal, 1995, 14(14):S77-83.
molnova catalog
related products
  • Dianemycin

    Dianemycin is a broad spectrum polyether antibiotic, inhibits gram-positive bacteria.

  • Ceftobiprole

    Ceftobiprole is a broad-spectrum cephalosporin with activity against Methicillin-resistant staphylococcus aureus.

  • DS-2969b

    DS-2969b (DS 11960558) is a novel orally active GyrB inhibitor, inhibits the supercoiling activity of C. difficile DNA gyrase with IC50 of 20 ng/mL.